Your browser doesn't support javascript.
loading
Vascular tumors of intermediate malignancy: An update.
Folpe, Andrew L.
Affiliation
  • Folpe AL; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55902, United States. Electronic address: folpe.andrew@mayo.edu.
Hum Pathol ; 147: 114-128, 2024 May.
Article in En | MEDLINE | ID: mdl-38360216
ABSTRACT
The term "hemangioendothelioma" is used for endothelial neoplasms of intermediate malignancy and describes a group of rare neoplasms having biologic behavior falling in between that of the benign hemangiomas and fully malignant angiosarcomas. The hemangioendotheliomas fall into several specific, clinicopathologically and genetically distinct entities, specifically epithelioid hemangioendothelioma, kaposiform hemangioendothelioma, papillary intralymphatic angioendothelioma and retiform hemangioendothelioma (hobnailed hemangioendothelioma), pseudomyogenic hemangioendothelioma, composite hemangioendothelioma, and YAP1TFE3-fused hemangioendothelioma. The clinical, morphologic, immunohistochemical, and genetic features, and the differential diagnosis of each of these rare entities are discussed in this review.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Hemangioendothelioma Limits: Humans Language: En Journal: Hum Pathol / Hum. pathol / Human pathology Journal subject: PATOLOGIA Year: 2024 Document type: Article Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Hemangioendothelioma Limits: Humans Language: En Journal: Hum Pathol / Hum. pathol / Human pathology Journal subject: PATOLOGIA Year: 2024 Document type: Article Country of publication: Estados Unidos